chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I experienced after my run, I jumped into the showery, I had a raised rash and hive on the front of my thighs, across my stomach and chest. It faded on its own about 3-4 hours later. I did not receive any treatment and my doctor suggested for me to take Benadryl if the rash re-appears.  My symptoms have resolved.
Developed itching in right arm that he received shot in. Then developed raised pruritic erythematous maculopapular rash over right hand and wrist. Pt also had rt eyelid swelling and itching.
Fever 103, local reaction at injection site. To ER if fever persists. Frothing at the mouth. Tylenol every 3 hours prn fever, check temp every 30 minutes.
Vertigo symptoms occurred 4/6/2021 less than 24 hours after vaccine was given.  They persisted for 3 days along with balance issues. on 4/9/2021 at 6:50 am stroke type symptoms occurred with slurred speech and paralysis on Let side arm and leg.  Several stroke episodes, and blood pressure spiking occurred over a 3 hour period. Low grade fever presented on 4/11/2021.  After much testing she was diagnosed with a series of TIA attacks found to be and averse effect from The COVID vaccine.
Cellulitis, itching, fever, muscle aches, redness, shortness of breath.
Severe chills, headache, fatigue, cough. MOTRIN, TYLENOL, ROBITUSSIN.
On 10/07/2020 she began feeling pain under her left arm.  She was seen in our office on 10/10/20 and examined. She has 2 to 3 firm lymph nodes in her axilla. They are not reddened.  She was placed on Reflex in case of infection. Pain was improving
ACHY; HEADACHE; This spontaneous report received from a parent via a company representative concerned a male of unspecified age. The patient's height and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously treated with covid-19 vaccine ad26. cov2. s (dose in series 1, unspecified manufacturer) for prophylactic vaccination.  The patient received booster dose with covid-19 vaccine ad26.cov2.s (Janssen series 2) (suspension for injection, route of admin and batch number were not reported) dose was not reported, 1 total, administered on 30-NOV-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On the night of 30-NOV-2021, the patient experienced achy and headache (dose series 2), but by the next day morning he was able to work a full shift. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the achy and headache was not reported. This report was non-serious.
Pt was given ZOSTAVAX, 10 minutes after receiving vaccine in left arm pt c/o terrible itching.  Left side of chest 5 inch area of redness noted on left side spreading to her back.  No redness or itching at injection site pt c/o feeling flushed.  BP 170/102, AP 84 reg.  Denies any difficult tx breathing.  Telephone call to PCP who ordered BENADRYL 25 mg two tabs now.  Pt took BENADRYL at 4:35 PM.  Ice pack applied to red, itching area left side of chest (under arm) 4:45 PM.  BP 150/98, AP 84 regular.  Rash continues to spread, pt c/o itching.  Pt denies difficulty breathing.  Pt was instructed she needed to go to local emergency room for evaluation.  Pt request RN call her PCP (primary care physician) pt does not want to go to ER due to the cost.  4:50 PM telephone call to PCP spoke with office nurse, PCP has left the office, no other provider is in the office.  Pt is agreeable to go to emergency room.  She refuses transport via ambulance, pt is willing to have her husband drive her.  5 PM BP 152/98, AP 84 reg.  Pt denies any difficulty breathing, continues to c/o itching under left arm redness continues.  Pt. to ER informed pt RN will call her tomorrow:  5 PM telephone call to hospital ER spoke with nurse informed pt coming to ER & given history.  5:30 PM husband called to confirm they were in ER - RN.  3/31/2010 8 AM telephone call to pt. RN asking how she was doing?  Pt states she has no itching or redness left lateral side of chest has scratch marks & soreness from itching.  Pt denied having any difficulty breathing and no redness or itching at injection site.  Pt was given PREDNISONE in the ER & was sent home on PREDNISONE 20 mg 3 tabs a day X 4 days by mouth.  Continue BENADRYL if needed. - RN.  3/31/2010 telephone call to Hosp..... spoke with infection control manager who confirmed treatment plan.  Diagnosis rash, itching no difficulty breathing after receiving ZOSTAVAX - Allergic reaction - RN.
Upon completion of MMR inject pt c/o dizziness, numbness, heavness of lt arm & forearm; dizziness resolved-no SOB-BP 100/50- 105/60;
expired vaccine used; no adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) and NO ADVERSE EVENT (no adverse event) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (expired vaccine used).    No concomitant medication was reported. It was reported that they dispensed 2 expired vaccines on 6-Dec-2022. They expired on 24-Nov-2022. It was the monovalent vaccine with lot number 053B22A. It was first thawed on 6-Dec-2022. The vial was exposed to room temperature for about 15-20 minutes. No treatment medication was reported.
Bed bound, severe arm pain, could not move, racing heart, felt like has a virus, worse symptom: Extreme spasms and uncontrollably full body shaking all night. Looks like a seizure with how dramatic body was spasming. As time went on, had several SVT attacks and worsened chronic migraines.
This spontaneous report was received from a nurse and refers to an 18-year-old patient. There was no information about the patient's medical history, concurrent conditions, and concomitant medications provided. On 21-AUG-2018, the patient received a dose of PROQUAD recombinant Human albumin (rHA), lot # R001543, expiration date 15-JUL-2019 (site and route of administration were not reported) for prophylaxis. The vaccine was reconstituted with sterile diluent.
patient was 33 wks gestation, G3P1A1, uncomplicated pregnancy ---received 3rd dose @ 33 wks gestation and baby ceased growing in utero from that time on  with birth weight of 5 pounds 1.3 ounces
Patient has no known past medical history other than COVID-19 pneumonia few months ago. He was treated with a regimen used in that country (details not available).  About a week ago, patient got 1st dose of COVID-19 vaccine.  Since then he has been having intermittent fevers, chills and has been progressive confused.  No nausea, vomiting, recent travel, rash, joint pain or swelling.  Currently not on any medications at home. On arrival, fever of 104.4, tachycardic, normal blood pressure Hospitalized and treated for suspected meningitis. CSF cultures came back negative for infectious process. Mental status, fever, improved over the course of 2-3 days. Infectious disease and Neurology evaluated the patient. Unclear etiology of symptoms, but given the recent dose of Pfizer vaccine,  it possibly could be related to vaccine. Patient is now improving, generally weak but otherwise recovered and will be discharged from the hospital to home.
Information has been received from a certified medical assistant concerning an adult male patient who on an unknown date was vaccinated (route unknown) with a dose of Pneumovax 23 (lot # 651319/1007P). After receiving the vaccine, the patient developed cellulitis starting from the injection site that went down his arm. He went to the emergency room and was hospitalized. The outcome of the patient's experience was not reported. No product complaint was involved. In follow up information, the medical assistant reported that she does not have patient information or lot number information. She reported that she can not confirm that the initial lot number reported was correct. She said "An antibiotic is sometimes ordered for a patient with cellulitis" but she does not know if the patient received an antibiotic. She has no further information to provide. Additional information is not expected.
Costochondritis.  Started several hours after vaccine.  Still active 3 weeks later.
1. Right side of jaw immediately got very tight and stiff and painful, still has not gone away 5 days later 2. Tip of tongue slowly became weird/numb feeling, has not subsided 5 days later
Same day as vaccination given, developed pain went from arm up to shoulder, to back, to neck to head - right side of body; chills/body aches
Very painful injection site, arm, hand, neck, shoulders, chest, lasting several days. Lethargy as well. Requested VAERS report. Recovery about 3-4 days.
I got shingles 2 weeks after. I got the shot; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 weeks after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient herself/himself. The age at vaccination was not reported. The patient had received shingles vaccine and 2 weeks after got shingles. The follow-up would not possible as no contact details were available.
Pt walked-in with rash on L arm, no fever, no pain, only itchiness. Pt was Rx'ed Prednisolone 15mg/5mL.
This spontaneous report was received from an office manager and refers to an unspecified number of patients of unknown age and gender. The patients' pertinent medical histories, drug reactions or allergies and concomitant medications were not reported. On unknown dates approximately in November 2016, the patients were vaccinated with improperly stored doses of GARDASIL 9 injection, lot # M023169, expiration date 13-JUN-2018, lot # M017983, expiration date 30-MAY-2018, lot # M030380, expiration date 01-FEB-2019 and lot # L019297, expiration date 18-AUG-2017 (dose, route and site of administration were not reported). No adverse effects were reported. Product quality complaint was not involved. The administered doses of GARDASIL 9 were stored in the temperature of 47.7 degrees Fahrenheit for 45 minutes on 18-NOV-2016, then in the temperature of 47.5 degrees Fahrenheit for 15 minutes, in the temperature of 48.4 degrees Fahrenheit for 30 minutes and in the temperature of 31.6 degrees Fahrenheit for 5.5 hours (1 cycle) on 19-NOV-2016, then in the temperature of 29.7 degrees Fahrenheit for 11 hours (1 cycle) and in the temperature of 33.4 degrees Fahrenheit for 15 minutes (1 cycle) on 20-NOV-2016. Data logger was involved. There were no previous temperature excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sore shoulder.  Ongoing for a couple of weeks (as of 11/5/15) but not sure of specific date when it began.
I95.9 HYPOTENSION 5/17/2021 RIGHT PUBIS UNSPECIFIED TYPE FX, INIT
Febrile illness with seizures, respiratory insufficiency with assisted ventilation. Dx: Metabolic Acidosis.
No adverse effect; the second dose of MMR was administered at a longer than recommended time interval from the first dose; Information has been received from a pharmacist referring to a female child of unknown age. Information about medical history, concurrent condition and concomitant medication was unknown.   On an unspecified date in 1960, the patient was vaccinated with her first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(manufacturer unknown) (strength, dose, therapy type, route, lot# and expiration date were unspecified) with sterile diluent for prophylaxis. On an unspecified date in 1964 the patient received second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) with sterile diluent (inappropriate schedule of product administration). It was unknown how sterile diluent was stored. It was possible that the second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(manufacturer unknown) was administered at a longer than recommended time interval from the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(manufacturer unknown) as dosing interval was unknown. No adverse effect was reported.
Within 4 hours of vaccine I started having chills and achiness and just generally feeling unwell. By 10 PM I had a fever and just felt horrible. I couldn't get comfy and my temperature was 103.4 and I waited 4 hours before taking Tylenol and it came down to 100.1. As soon as the Tylenol worse off the fever would spike again. This lasted around 36 hours with the achiness and felt like the worse flu I ever had.
Pt presented to ER with upper abd pain and diffuse rash, and mild headache. No fever, pulse oximetry 98%.
Watery stools every day since april and continues; Stomach was upset; Fever; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (Watery stools every day since april and continues), ABDOMINAL DISCOMFORT (Stomach was upset) and PYREXIA (Fever) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 027B21A) for COVID-19 vaccination.     The patient's past medical history included Stools watery (20 years ago).   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced DIARRHOEA (Watery stools every day since april and continues), ABDOMINAL DISCOMFORT (Stomach was upset) and PYREXIA (Fever). On 29-Apr-2021, PYREXIA (Fever) had resolved. On 01-May-2021, ABDOMINAL DISCOMFORT (Stomach was upset) had resolved. At the time of the report, DIARRHOEA (Watery stools every day since april and continues) had not resolved.            Concomitant medications were not reported by the reporter Treatment drugs were not reported by the reporter   This case was linked to MOD-2021-319094 (Patient Link).
Shortness of breath , blurred vision and dizzy on top of chest pain and my arms and legs getting numb .  Heart rate constantly high in the 100s while standing amd blood pressure very high now 150/90.  Having rally bad headaches.   All above which is not normal at all for me.    Also, Very fatigued and can not drive or work now.  Had to go to the ER on the 18the due to feeling like I was having a heart attack.  Very bad chest pains and dizziness shortness of breath,  and blurred vision.   Can?t sleep well always feeling like my body is hot .
Patient received the 2nd dose of Moderna COVID vaccine on 7-23-22 in the afternoon.. The next evening, 7-24-22, he started experiencing hives on his neck and abdomen.  He took benadryl tablets and went to sleep. Monday morning, 7-25-22, the hives were still there, and maybe a little worse.  He called pharmacy to inform and also called his doctor.
At about ten minutes after the injection, My vision got blurry and I felt dizzy.  I went to sit down and my heart started racing.  I felt very weak and tired.  I laid down and the Pharmacist asked me some questions.  He told me to breathe and asked if I was having trouble breathing.  I was not.  My chest felt a little tight but my breathing was totally fine.  I was tingly and nauseous.  He said it was probably anxiety.  It might have been.  I just wanted to report it.
Refridgeration excursions identified/vaccines have undergone several temperature excursions; No adverse event; Poor quality product administered; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified/vaccines have undergone several temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered) and NO ADVERSE EVENT (No adverse event) in a 65-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 18-Sep-2022 at 6:46 AM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 18-Sep-2022 at 6:46 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified/vaccines have undergone several temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified/vaccines have undergone several temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Refridgeration excursions identified/vaccines have undergone several temperature excursions) and POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered).    No concomitant products reported.  It was reported that refrigeration excursions identified, state vaccine was housed in these units. There were excursions noted. Manufactures were notified and the state department and made aware of the situation. The Nurse called for a clinic that she was assisting. The clinic had a similar issue with vaccines stored in their freezer. Vaccines stored in the refrigerator that underwent several temperature excursions going back to Aug-2022. Date vial moved from freezer to refrigerator was 07-Sep-2022. The vial underwent temperature excursion.  No adverse reactions reported for the patient.  No treatment products reported.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021 at 11:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 12-Jan-2021 at 11:00 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 36.88 for dose administered on 12-Jan-2021   No concomitant and treatment medications were reported.  Batch number 041L20A underwent temperature excursion on 12-Jan-2021 with temperature 34,34 degrees Fahrenheit from 08:00 AM to 09:00 AM. This vial was moved to fridge on 08-JAN-2021 and beyond use date for the vial was reported as 07-FEB-2021. Product moved to clinic on 12-Jan-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.   This case was linked to MOD-2022-566976 (Patient Link).
shingles; Information has been received from a lawyer concerning a case in litigation and refers to a currently 69-year-old male patient. No information regarding the pt's medical history, concurrent conditions and concomitant medications was reported. In or about 2012, the pt was administered with zoster vaccine live (ZOSTAVAX) vaccine (dose, route of administration, vaccination site, lot # and expiry date were not specified) at the physician office for the long-term prevention of shingles and zoster-related conditions. As a result pf his receipt of zoster vaccine live (ZOSTAVAX), the pt was caused to suffer shingles in or about 2012, including and all of it sequelae and was subsequently treated by a provider. As a result of his receipt of zoster vaccine live (ZOSTAVAX) , the pt has been caused to suffer severe personal injuries, pain, suffering, and emotional distress, as well as to incur substantial economic damages. As a direct and proximate result of zoster vaccine live (ZOSTAVAX)'s manufacturing defect, the pt suffered severe and permanent physical injuries, including but not limited to shingles, as well as other severe and permanent health consequences. The pt has endured substantial pain and suffering. The pt has incurred significant expenses for medical care and treatment, and will continue to incur such expenses in the future. The pt has lost past earnings and has suffered a loss of earning capacity. The pt has suffered and would continue to suffer economic loss, and has otherwise been physically, emotionally and economically injured. The pt's injuries and damages ware permanent and would continue into the future. The pt sought actual and punitive damages from the Company as alleged herein. the pt demanded judgment against Company for compensatory, treble, and punitive damages, together with interest, costs of suit, attorneys' fees, and all such other relief as the Court deems proper. The outcome of shingles was reported as not recovered. The causality was related.  The event of shingles was considered to be disabling.